Intermittent Fasting for Pancreatitis
Key facts
- Who runs it
- H. Lee Moffitt Cancer Center and Research Institute
- Where
- Tampa, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 64 people, planned
- Starts
- Sept 2027
- Expected to end
- Mar 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Intermittent Fasting
- No intermittent fasting
- Record updated
- 17 September 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Age ≥ 18 year
- Recurrent acute pancreatitis defined by greater than 2 episodes of pancreatitis, defined by:; abdominal pain and either amylase or lipase > 3 x the upper limit of normal, imaging suggestive of, separated by time
- Anatomy of chronic pancreatitis defined by Rosemont criterion9 or on imaging (CT, MRI)
- Pancreatic exocrine insufficiency defined by a pancreatic elastase < 200 ug/g stool10
Who cannot take part
- Glycogen storage disease
- Patients with diabetes
- Age < 18 years
- Age > 80 years
- Pregnant Patients
- Patients who cannot consent for themselves
- Insulinoma or hypoglycemic state
- Active alcohol abuse
- Alcohol induced acute pancreatitis
- Gallstone induced acute pancreatitis
- Pancreatic solid neoplasm
- Patients on beta blockers
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in United States
- Moffitt Cancer CenterTampa, United StatesContact: Shaffer Mok, MDNot yet recruiting
About the trial
What the trial wants to find out
The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.
The 2 groups in the trial
- Intermittent FastingTreatment being tested
Patients in Group A will then receive information regarding intermittent fasting, which would include fasting for a 16-hour period each day, followed by ingestion of an appropriate number of calories for the remaining part of the day.
- ControlExisting treatment, for comparison
These subjects will undergo standard caloric dietary guidance. Patients in group B will also be given the above information, though not be asked to intermittently fast.
Treatment: No intermittent fasting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intermittent Fasting as a Primary Means for Improving Quality of Life for Acute and Chronic Pancreatitis
- Criteria questions
- Built from NCT04760847, who can take part
- Record updated
- 17 September 2026